vs
Side-by-side financial comparison of Allstate (ALL) and OLIN Corp (OLN). Click either name above to swap in a different company.
OLIN Corp is the larger business by last-quarter revenue ($1.7B vs $922.0M, roughly 1.8× Allstate). Allstate runs the higher net margin — 266.6% vs -8.6%, a 275.2% gap on every dollar of revenue. On growth, Allstate posted the faster year-over-year revenue change (7.2% vs -0.4%). Over the past eight quarters, OLIN Corp's revenue compounded faster (0.9% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
ALL vs OLN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $1.7B |
| Net Profit | $2.5B | $-143.2M |
| Gross Margin | — | 1.9% |
| Operating Margin | -1400.3% | -9.4% |
| Net Margin | 266.6% | -8.6% |
| Revenue YoY | 7.2% | -0.4% |
| Net Profit YoY | — | -1517.8% |
| EPS (diluted) | $9.25 | $-1.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $1.7B | ||
| Q3 25 | $17.3B | $1.7B | ||
| Q2 25 | $16.6B | $1.8B | ||
| Q1 25 | $16.5B | $1.6B | ||
| Q4 24 | $16.5B | $1.7B | ||
| Q3 24 | $16.6B | $1.6B | ||
| Q2 24 | $15.7B | $1.6B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $-143.2M | ||
| Q3 25 | $3.7B | $43.7M | ||
| Q2 25 | $2.1B | $-2.8M | ||
| Q1 25 | $595.0M | $1.2M | ||
| Q4 24 | $1.9B | $10.1M | ||
| Q3 24 | $1.2B | $-25.2M | ||
| Q2 24 | $331.0M | $72.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | — | 14.5% |
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | -9.4% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 2.8% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 8.3% |
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | -8.6% | ||
| Q3 25 | 21.7% | 2.6% | ||
| Q2 25 | 12.7% | -0.2% | ||
| Q1 25 | 3.6% | 0.1% | ||
| Q4 24 | 11.7% | 0.6% | ||
| Q3 24 | 7.2% | -1.6% | ||
| Q2 24 | 2.1% | 4.4% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $-1.25 | ||
| Q3 25 | $13.95 | $0.37 | ||
| Q2 25 | $7.76 | $-0.01 | ||
| Q1 25 | $2.11 | $0.01 | ||
| Q4 24 | $7.07 | $0.10 | ||
| Q3 24 | $4.33 | $-0.21 | ||
| Q2 24 | $1.13 | $0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $167.6M |
| Total DebtLower is stronger | — | $2.8B |
| Stockholders' EquityBook value | $31.6B | $1.8B |
| Total Assets | $124.0B | $7.3B |
| Debt / EquityLower = less leverage | — | 1.55× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $167.6M | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $6.5B | — | ||
| Q4 24 | $4.5B | $175.6M | ||
| Q3 24 | $7.0B | — | ||
| Q2 24 | $5.3B | — |
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $2.8B | ||
| Q3 25 | $8.1B | $3.0B | ||
| Q2 25 | $8.1B | $3.0B | ||
| Q1 25 | $8.1B | $3.0B | ||
| Q4 24 | $8.1B | $2.7B | ||
| Q3 24 | $8.1B | $2.8B | ||
| Q2 24 | $8.1B | $2.8B |
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $1.8B | ||
| Q3 25 | $27.5B | $2.0B | ||
| Q2 25 | $24.0B | $2.0B | ||
| Q1 25 | $22.1B | $2.0B | ||
| Q4 24 | $21.4B | $2.0B | ||
| Q3 24 | $20.9B | $2.1B | ||
| Q2 24 | $18.6B | $2.1B |
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $7.3B | ||
| Q3 25 | $120.4B | $7.6B | ||
| Q2 25 | $115.9B | $7.7B | ||
| Q1 25 | $115.2B | $7.7B | ||
| Q4 24 | $111.6B | $7.6B | ||
| Q3 24 | $113.7B | $7.5B | ||
| Q2 24 | $108.4B | $7.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | 1.55× | ||
| Q3 25 | 0.29× | 1.52× | ||
| Q2 25 | 0.34× | 1.52× | ||
| Q1 25 | 0.37× | 1.50× | ||
| Q4 24 | 0.38× | 1.34× | ||
| Q3 24 | 0.39× | 1.34× | ||
| Q2 24 | 0.43× | 1.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $321.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $321.2M | ||
| Q3 25 | $3.3B | $26.7M | ||
| Q2 25 | $1.9B | $212.3M | ||
| Q1 25 | $2.0B | $-86.0M | ||
| Q4 24 | $1.7B | $141.7M | ||
| Q3 24 | $3.2B | $189.9M | ||
| Q2 24 | $2.4B | $90.6M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $3.2B | $-44.4M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | $-147.4M | ||
| Q4 24 | $1.7B | $90.7M | ||
| Q3 24 | $3.1B | $146.6M | ||
| Q2 24 | $2.3B | $34.1M |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | — | ||
| Q3 25 | 18.8% | -2.6% | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | 11.4% | -9.0% | ||
| Q4 24 | 10.0% | 5.4% | ||
| Q3 24 | 18.9% | 9.2% | ||
| Q2 24 | 14.7% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.3% | 4.2% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.6% | 3.7% | ||
| Q4 24 | 0.3% | 3.1% | ||
| Q3 24 | 0.4% | 2.7% | ||
| Q2 24 | 0.4% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.88× | 0.61× | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 3.30× | -71.67× | ||
| Q4 24 | 0.88× | 14.03× | ||
| Q3 24 | 2.69× | — | ||
| Q2 24 | 7.13× | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALL
Segment breakdown not available.
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
